Why Should You Put GSK Plc ADR (NYSE: GSK) On Your Portfolio?

Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade.

Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


However, the script later moved the day high at 41.41, down -2.00%. The company’s stock has a 5-day price change of -1.20% and 19.18% over the past three months. GSK shares are trading 10.82% year to date (YTD), with the 12-month market performance up to 12.74% higher. It has a 12-month low price of $33.20 and touched a high of $42.21 over the same period. GSK has an average intraday trading volume of 2.01 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.32%, 7.00%, and 13.40% respectively.

Institutional ownership of GSK Plc ADR (NYSE: GSK) shares accounts for 14.35% of the company’s 2.03B shares outstanding.

It has a market capitalization of $83.34B and a beta (3y monthly) value of 0.66. The stock’s trailing 12-month PE ratio is 13.73, while the earnings-per-share (ttm) stands at $2.99. The company has a PEG of 2.86 and a Quick Ratio of 0.62 with the debt-to-equity ratio at 1.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 0.98% over the week and 1.28% over the month.

Analysts forecast that GSK Plc ADR (GSK) will achieve an EPS of $GSK plc for the current quarter, $41.07 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $FS KKR Capital Corp. while analysts give the company a high EPS estimate of $Global Ship Lease Inc New. Comparatively, EPS for the current quarter was $Genco Shipping & Trading Limite a year ago. Earnings per share for the fiscal year are expected to decrease by -2.06%, and 12.48% over the next financial year. EPS should grow at an annualized rate of 4.80% over the next five years, compared to 4.23% over the past 5-year period.

Looking at the support for the GSK, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on January 23, 2024, with the firm’s price target at $44.

Most Popular

Related Posts